144 related articles for article (PubMed ID: 21741629)
1. Melanoma-induced suppression of tumor antigen-specific T cell expansion is comparable to suppression of global T cell expansion.
Russ AJ; Xu K; Wentworth L; Alam S; Meyers JV; Macklin MD; Rakhmilevich AL; Rajamanickam V; Suresh M; Cho CS
Cell Immunol; 2011; 271(1):104-9. PubMed ID: 21741629
[TBL] [Abstract][Full Text] [Related]
2. Suppression of T-cell expansion by melanoma is exerted on resting cells.
Russ AJ; Wentworth L; Xu K; Rakhmilevich A; Seroogy CM; Sondel PM; Suresh M; Cho CS
Ann Surg Oncol; 2011 Dec; 18(13):3848-57. PubMed ID: 21465311
[TBL] [Abstract][Full Text] [Related]
3. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
5. Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice.
Mahvi DA; Meyers JV; Tatar AJ; Contreras A; Suresh M; Leverson GE; Sen S; Cho CS
J Immunother; 2015; 38(2):54-61. PubMed ID: 25658614
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
[TBL] [Abstract][Full Text] [Related]
8. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
9. 2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes.
Kolawole EM; Andargachew R; Liu B; Jacobs JR; Evavold BD
Front Immunol; 2018; 9():2348. PubMed ID: 30374353
[TBL] [Abstract][Full Text] [Related]
10. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM
J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266
[TBL] [Abstract][Full Text] [Related]
11. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
[TBL] [Abstract][Full Text] [Related]
12. Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope.
Mazeike E; Gedvilaite A; Blohm U
Virus Res; 2012 Jan; 163(1):2-10. PubMed ID: 21864590
[TBL] [Abstract][Full Text] [Related]
13. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
[TBL] [Abstract][Full Text] [Related]
14. Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
Bättig P; Saudan P; Storni T; Gallimore A; Bachmann MF
Microbes Infect; 2005 Apr; 7(4):729-37. PubMed ID: 15857805
[TBL] [Abstract][Full Text] [Related]
15. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.
Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A
J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292
[TBL] [Abstract][Full Text] [Related]
16. Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis Virus.
Smyth M; Khamina K; Popa A; Gudipati V; Agerer B; Lercher A; Kosack L; Endler L; Baazim H; Viczenczova C; Huppa JB; Bergthaler A
Front Immunol; 2021; 12():638485. PubMed ID: 34194424
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
Rawson P; Hermans IF; Huck SP; Roberts JM; Pircher H; Ronchese F
Cancer Res; 2000 Aug; 60(16):4493-8. PubMed ID: 10969797
[TBL] [Abstract][Full Text] [Related]
18. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion.
Aichele P; Unsoeld H; Koschella M; Schweier O; Kalinke U; Vucikuja S
J Immunol; 2006 Apr; 176(8):4525-9. PubMed ID: 16585541
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells efficiently induce protective antiviral immunity.
Ludewig B; Ehl S; Karrer U; Odermatt B; Hengartner H; Zinkernagel RM
J Virol; 1998 May; 72(5):3812-8. PubMed ID: 9557664
[TBL] [Abstract][Full Text] [Related]
20. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus.
Whitton JL; Gebhard JR; Lewicki H; Tishon A; Oldstone MB
J Virol; 1988 Mar; 62(3):687-95. PubMed ID: 2448497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]